• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上皮糖蛋白(EGP40)在口腔上皮异型增生和口腔鳞状细胞癌(OSCC)中的表达。

Expression of epithelial glycoprotein (EGP40) in oral epithelial dysplasia and oral squamous cell carcinoma (OSCC).

机构信息

Department of Oral and Maxillofacial Pathology, KSR Institute of Dental Science and Research, Thiruchengodu, Tamil Nadu, India.

Consultant Oral Pathologist, USA.

出版信息

Indian J Dent Res. 2020 Sep-Oct;31(5):738-742. doi: 10.4103/ijdr.IJDR_929_18.

DOI:10.4103/ijdr.IJDR_929_18
PMID:33433512
Abstract

AIM

To study the expression of Epithelial Glycoprotein (EGP40) in various grades of Oral Epithelial Dysplasia namely mild, moderate and severe epithelial dysplasia and in various grades of Oral Squamous Cell Carcinoma (OSCC) namely well, moderate & in poorly differentiated squamous cell carcinoma.

MATERIAL AND METHODS

This laboratory study comprised of 47 samples in which 27 samples were of three different grades of OSCC, Well (n=10), Moderate (n=10) and Poorly differentiated (n=7) and remaining 20 samples were of three different grades of dysplasia [Mild (n=7), Moderate (n=8), Severe dysplasia (n=5)]. All the 47 cases were subjected to immunohistochemical staining to evaluate the expression of EGP40. Chi square was used to analyze the significance of differences in different grades of oral epithelial dysplasia & in different grades of OSCC.

RESULTS

The percentage of EGP40 immuno positivity was increased from mild to severe dysplasia and the percentage of EGP40 immuno positivity was increased from well to poorly differentiated carcinoma No statistical significance was observed in the immunoreactivity and in the intensity of expression between various grades of oral epithelial dysplasia and oral squamous cell carcinoma.

CONCLUSION

The epithelial cell adhesion molecule can be considered as an early marker for predicting malignant transformation of dysplastic epithelial lesions and used as a marker in predicting the OSCC prognosis.

摘要

目的

研究上皮糖蛋白(EGP40)在不同程度的口腔上皮异型增生(轻度、中度和重度上皮异型增生)和不同分级的口腔鳞状细胞癌(OSCC)(高分化、中分化和低分化鳞状细胞癌)中的表达。

材料与方法

本实验室研究包括 47 例样本,其中 27 例为不同分级的 OSCC,高分化(n=10)、中分化(n=10)和低分化(n=7),其余 20 例为不同分级的异型增生[轻度(n=7)、中度(n=8)、重度异型增生(n=5)]。所有 47 例均进行免疫组织化学染色,以评估 EGP40 的表达。采用卡方检验分析不同分级口腔上皮异型增生和不同分级 OSCC 之间的差异。

结果

EGP40 免疫阳性率从轻度异型增生到重度异型增生逐渐增加,从高分化到低分化癌逐渐增加。在不同分级的口腔上皮异型增生和口腔鳞状细胞癌之间,免疫反应性和表达强度均无统计学意义。

结论

上皮细胞黏附分子可作为预测异型上皮病变恶性转化的早期标志物,并可作为预测 OSCC 预后的标志物。

相似文献

1
Expression of epithelial glycoprotein (EGP40) in oral epithelial dysplasia and oral squamous cell carcinoma (OSCC).上皮糖蛋白(EGP40)在口腔上皮异型增生和口腔鳞状细胞癌(OSCC)中的表达。
Indian J Dent Res. 2020 Sep-Oct;31(5):738-742. doi: 10.4103/ijdr.IJDR_929_18.
2
[Expression of RACK1 and EGP40 in oral squamous cell carcinoma and its correlation with clinicopathological features and prognosis].[RACK1和EGP40在口腔鳞状细胞癌中的表达及其与临床病理特征和预后的相关性]
Shanghai Kou Qiang Yi Xue. 2023 Aug;32(4):385-390.
3
Immunohistochemical expression of EGP40, a tumor marker, in different grades of oral squamous cell carcinoma.肿瘤标志物EGP40在不同分级口腔鳞状细胞癌中的免疫组化表达。
J Oral Maxillofac Pathol. 2011 Jan;15(1):34-8. doi: 10.4103/0973-029X.80038.
4
Immunohistochemical evaluation of E-cadherin in oral epithelial dysplasia and squamous cell carcinoma.免疫组织化学评估口腔上皮异型增生和鳞状细胞癌中的 E-钙黏蛋白。
Indian J Pathol Microbiol. 2022 Oct-Dec;65(4):755-760. doi: 10.4103/ijpm.ijpm_31_21.
5
E-cadherin Expression in Premalignant Lesions, Premalignant Conditions, Oral Squamous Cell Carcinoma, and Normal Mucosa: An Immunohistochemical Study.E-钙黏蛋白在前体病变、癌前状况、口腔鳞状细胞癌及正常黏膜中的表达:一项免疫组织化学研究
Cureus. 2023 Aug 28;15(8):e44266. doi: 10.7759/cureus.44266. eCollection 2023 Aug.
6
Immunohistochemical Expression of Epidermal Growth Factor Receptor (EGFR) in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.口腔鳞状细胞癌和口腔潜在恶性疾病中表皮生长因子受体(EGFR)的免疫组织化学表达。
Appl Immunohistochem Mol Morphol. 2024 Mar 1;32(3):157-162. doi: 10.1097/PAI.0000000000001185. Epub 2024 Jan 25.
7
Immunohistochemical expression of Bcl-2 in oral epithelial dysplasia and oral squamous cell carcinoma.Bcl-2在口腔上皮异常增生及口腔鳞状细胞癌中的免疫组化表达
Indian J Cancer. 2015 Oct-Dec;52(4):505-10. doi: 10.4103/0019-509X.178411.
8
MUC4 Expression in Oral Dysplastic Epithelium and Oral Squamous Cell Carcinoma: An Immunohistochemical Study.MUC4在口腔发育异常上皮和口腔鳞状细胞癌中的表达:一项免疫组织化学研究。
J Int Soc Prev Community Dent. 2023 Apr 28;13(2):124-132. doi: 10.4103/jispcd.JISPCD_241_22. eCollection 2023 Mar-Apr.
9
Comparison of PD-L1 Expression in Oral Squamous Cell Carcinoma and Premalignant Lesions of Oral Cavity.口腔鳞状细胞癌与口腔癌前病变中 PD-L1 表达的比较。
Asian Pac J Cancer Prev. 2022 Dec 1;23(12):4039-4045. doi: 10.31557/APJCP.2022.23.12.4039.
10
Immunohistochemical Evaluation of E- Cadherin in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.E-钙黏蛋白在口腔上皮发育异常及口腔鳞状细胞癌中的免疫组化评估
J Pharm Bioallied Sci. 2024 Apr;16(Suppl 2):S1838-S1842. doi: 10.4103/jpbs.jpbs_38_24. Epub 2024 Apr 16.